PositiveID Corporation (OTCQB: PSID) is an emerging growth company that develops biological detection and diagnostic systems for America's homeland defense and the global healthcare market. PositiveID specializes in microfluidic systems for the automated preparation and performance of biological assays in order to detect biological threats and outbreaks whether airborne, in a healthcare setting, or at the point of need.
Nov 18, 2015
PositiveID Corporation to Present at the LD MICRO "Main Event" Investor Conference on December 2, 2015
Nov 13, 2015
PositiveID Corporation Reports Record Revenue of $2.7 Million for the Nine Months Ended September 30, 2015